Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gabapentin in generalized seizures

D Chadwick1, D B Leiderman, W Sauermann

  • 1Department of Medical and Surgical Neurology, Walton Hospital, Liverpool, UK.

Epilepsy Research
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Massive bowel resection for children with non-short bowel syndrome intestinal failure.

Intestinal Failure (New York, N.Y.)·2026
Same author

HIV testing in primary care in a low-prevalence area of Northeast England.

HIV medicine·2025
Same author

British HIV Association guidelines on the management of opportunistic infection in people living with HIV: Considerations in pregnancy 2024.

HIV medicine·2024
Same author

Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19.

International journal of antimicrobial agents·2023
Same author

Safe provision of elective endocrine surgery operations amid the COVID-19 crisis.

Annals of the Royal College of Surgeons of England·2021
Same author

Author response: Post-thyroidectomy bleeding: analysis of risk factors from a national registry.

The British journal of surgery·2021
Same journal

Comment on "Predictors of surgical outcome in frontal lobe epilepsy: Experience from a single-center cohort in Latin America".

Epilepsy research·2026
Same journal

Response to: "A critical appraisal of principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam".

Epilepsy research·2026
Same journal

Access to inpatient video-EEG monitoring for patients with frequent seizure-related emergency visits.

Epilepsy research·2026
Same journal

Effect of the ketogenic diet on absence seizures in rats with genetic absence epilepsy.

Epilepsy research·2026
Same journal

Diagnostic accuracy of artificial intelligence models for seizure outcome prediction after epilepsy surgery: A systematic review and meta-analysis.

Epilepsy research·2026
Same journal

Quality assessment of persian epilepsy mobile applications: A systematic review using uMARS and DISCERN.

Epilepsy research·2026
See all related articles

This study evaluated gabapentin for generalized seizures. While showing a trend in reducing tonic-clonic seizures, results were not statistically significant, indicating further research is needed.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Refractory generalized seizures pose a significant challenge in epilepsy management.
  • Antiepileptic drugs (AEDs) are the cornerstone of treatment, but many patients require add-on therapies.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of gabapentin (Neurontin) as an add-on therapy for patients with refractory generalized seizures.
  • To determine if gabapentin significantly reduces seizure frequency compared to placebo.

Main Methods:

  • A 14-week, double-blind, placebo-controlled, parallel-group, multicenter study.
  • 129 patients with refractory generalized seizures received standard AEDs plus either 1200 mg/day gabapentin or placebo.
  • Seizure frequency was monitored during a 12-week baseline and a 14-week evaluation period.

Related Experiment Videos

Main Results:

  • Gabapentin showed a trend towards reducing the frequency of generalized tonic-clonic seizures compared to placebo, but the difference was not statistically significant.
  • Gabapentin did not significantly impact the frequency of absence or myoclonic seizures.
  • Adverse events were more common in the gabapentin group (67%) than the placebo group (56%), with somnolence, fatigue, and dizziness being most frequent.

Conclusions:

  • Gabapentin was well-tolerated in patients with generalized seizures.
  • The study suggests a potential trend for gabapentin in managing generalized tonic-clonic seizures.
  • Further investigation into high-dose gabapentin for generalized epilepsy is warranted.